US Stock MarketDetailed Quotes

COGT Cogent Biosciences

Watchlist

8.980
-0.100-1.10%

Close Nov 21 16:00 ET

8.980
0.0000.00%

Post 16:20 ET

991.95MMarket Cap-3620P/E (TTM)

Cogent Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-36.90%-51.98M

-33.17%-42.7M

-32.93%-52.53M

-29.49%-153.62M

-49.86%-44.07M

-10.25%-37.97M

-21.21%-32.07M

-39.47%-39.52M

-101.89%-118.64M

-41.54%-29.41M

Net income from continuing operations

-27.54%-70.63M

-33.75%-58.95M

-51.21%-58.35M

-37.20%-192.41M

-37.22%-54.37M

-57.95%-55.38M

-26.19%-44.08M

-25.96%-38.59M

-94.04%-140.24M

-59.03%-39.62M

Operating gains losses

----

--8K

----

Depreciation and amortization

28.30%1.1M

-11.18%1.08M

47.44%1.07M

-38.96%3.59M

-15.26%794K

-76.96%855K

81.49%1.22M

29.11%723K

195.23%5.88M

71.61%937K

Other non cash items

----

-25.00%-1.7M

--0

---1.7M

-296.50%-1.36M

----

Change In working capital

94.41%13.4M

-41.03%2.58M

31.85%-3.24M

1,423.57%11.44M

-27.06%4.94M

200.45%6.89M

33.70%4.37M

-95.48%-4.76M

326.70%751K

2,677.19%6.78M

-Change in prepaid assets

141.63%746K

-60.43%-592K

-248.73%-1.1M

57.87%-626K

13.35%1.85M

18.91%-1.79M

-114.53%-369K

57.12%-316K

-554.63%-1.49M

-2.04%1.63M

-Change in payables and accrued expense

45.18%13M

-27.51%3.51M

57.18%-1.81M

8.69%12.98M

-38.51%3.42M

179.12%8.96M

97.39%4.84M

-678.25%-4.23M

93.22%11.95M

1,770.03%5.55M

-Change in other current assets

--0

93.33%-2K

88.31%-119K

-108.70%-2K

-168.50%-87K

--0

98.40%-30K

72.69%-1.02M

101.36%23K

-Change in other current liabilities

-88.83%-355K

-235.64%-339K

-76.47%-330K

90.84%-796K

25.93%-320K

97.65%-188K

-136.46%-101K

66.00%-187K

-323.49%-8.69M

19.40%-432K

Cash from discontinued investing activities

Operating cash flow

-36.90%-51.98M

-33.17%-42.7M

-32.93%-52.53M

-29.49%-153.62M

-49.86%-44.07M

-10.25%-37.97M

-21.21%-32.07M

-39.47%-39.52M

-101.89%-118.64M

-41.54%-29.41M

Investing cash flow

Cash flow from continuing investing activities

166.48%60.19M

-8.97%-84.63M

-98.26%1.04M

21.56%-97.82M

-63.08%10.49M

40.26%-90.54M

-6,688.55%-77.66M

13,679.14%59.88M

-7,155.26%-124.72M

6,661.43%28.41M

Net PPE purchase and sale

-131.40%-280K

88.23%-148K

93.65%-70K

59.26%-2.8M

83.99%-315K

96.35%-121K

-9.88%-1.26M

-150.11%-1.1M

-299.24%-6.86M

-354.27%-1.97M

Net investment purchase and sale

166.88%60.47M

-10.57%-84.48M

-98.17%1.11M

19.37%-95.03M

-64.43%10.8M

39.00%-90.42M

---76.4M

--60.99M

---117.86M

--30.38M

Cash from discontinued investing activities

Investing cash flow

166.48%60.19M

-8.97%-84.63M

-98.26%1.04M

21.56%-97.82M

-63.08%10.49M

40.26%-90.54M

-6,688.55%-77.66M

13,679.14%59.88M

-7,155.26%-124.72M

6,661.43%28.41M

Financing cash flow

Cash flow from continuing financing activities

-37.60%624K

-100.16%-256K

48,002.70%214.06M

-0.01%163.54M

1.01%1M

-0.01%162.09M

222.46%445K

330.69%163.56M

-99.17%315K

Net common stock issuance

--0

-100.23%-365K

--213.7M

-0.08%161.82M

--0

0.00%-170K

--161.99M

--0

326.10%161.95M

--0

Proceeds from stock option exercised by employees

-46.67%624K

6.86%109K

-20.00%356K

6.45%1.72M

--0

0.86%1.17M

--102K

222.46%445K

2,832.73%1.61M

--315K

Cash from discontinued financing activities

Financing cash flow

-37.60%624K

-100.16%-256K

48,002.70%214.06M

-0.01%163.54M

--0

1.01%1M

-0.01%162.09M

222.46%445K

330.69%163.56M

-99.17%315K

Net cash flow

Beginning cash position

-58.84%88.22M

33.25%215.8M

-62.29%53.23M

-36.12%141.14M

-38.79%86.81M

-34.42%214.32M

-15.78%161.95M

-36.12%141.14M

-9.24%220.94M

-30.53%141.82M

Current changes in cash

106.92%8.83M

-343.64%-127.58M

681.15%162.57M

-10.17%-87.91M

-4,823.90%-33.58M

31.08%-127.51M

-61.07%52.36M

172.68%20.81M

-254.56%-79.8M

-104.06%-682K

End cash Position

11.79%97.05M

-58.84%88.22M

33.25%215.8M

-62.29%53.23M

-38.79%86.81M

-34.42%214.32M

-15.78%161.95M

-36.12%141.14M

Free cash flow

-37.20%-52.26M

-28.59%-42.85M

-29.49%-52.6M

-24.64%-156.42M

-41.47%-44.39M

-0.90%-38.09M

-20.74%-33.32M

-41.16%-40.62M

-107.50%-125.5M

-47.93%-31.38M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-36.90%-51.98M	-33.17%-42.7M	-32.93%-52.53M	-29.49%-153.62M	-49.86%-44.07M	-10.25%-37.97M	-21.21%-32.07M	-39.47%-39.52M	-101.89%-118.64M	-41.54%-29.41M
Net income from continuing operations	-27.54%-70.63M	-33.75%-58.95M	-51.21%-58.35M	-37.20%-192.41M	-37.22%-54.37M	-57.95%-55.38M	-26.19%-44.08M	-25.96%-38.59M	-94.04%-140.24M	-59.03%-39.62M
Operating gains losses	----	----	----	--8K	----	----	----	----	----	----
Depreciation and amortization	28.30%1.1M	-11.18%1.08M	47.44%1.07M	-38.96%3.59M	-15.26%794K	-76.96%855K	81.49%1.22M	29.11%723K	195.23%5.88M	71.61%937K
Other non cash items	----	----	----	-25.00%-1.7M	--0	--0	--0	---1.7M	-296.50%-1.36M	----
Change In working capital	94.41%13.4M	-41.03%2.58M	31.85%-3.24M	1,423.57%11.44M	-27.06%4.94M	200.45%6.89M	33.70%4.37M	-95.48%-4.76M	326.70%751K	2,677.19%6.78M
-Change in prepaid assets	141.63%746K	-60.43%-592K	-248.73%-1.1M	57.87%-626K	13.35%1.85M	18.91%-1.79M	-114.53%-369K	57.12%-316K	-554.63%-1.49M	-2.04%1.63M
-Change in payables and accrued expense	45.18%13M	-27.51%3.51M	57.18%-1.81M	8.69%12.98M	-38.51%3.42M	179.12%8.96M	97.39%4.84M	-678.25%-4.23M	93.22%11.95M	1,770.03%5.55M
-Change in other current assets	--0	--0	93.33%-2K	88.31%-119K	-108.70%-2K	-168.50%-87K	--0	98.40%-30K	72.69%-1.02M	101.36%23K
-Change in other current liabilities	-88.83%-355K	-235.64%-339K	-76.47%-330K	90.84%-796K	25.93%-320K	97.65%-188K	-136.46%-101K	66.00%-187K	-323.49%-8.69M	19.40%-432K
Cash from discontinued investing activities
Operating cash flow	-36.90%-51.98M	-33.17%-42.7M	-32.93%-52.53M	-29.49%-153.62M	-49.86%-44.07M	-10.25%-37.97M	-21.21%-32.07M	-39.47%-39.52M	-101.89%-118.64M	-41.54%-29.41M
Investing cash flow
Cash flow from continuing investing activities	166.48%60.19M	-8.97%-84.63M	-98.26%1.04M	21.56%-97.82M	-63.08%10.49M	40.26%-90.54M	-6,688.55%-77.66M	13,679.14%59.88M	-7,155.26%-124.72M	6,661.43%28.41M
Net PPE purchase and sale	-131.40%-280K	88.23%-148K	93.65%-70K	59.26%-2.8M	83.99%-315K	96.35%-121K	-9.88%-1.26M	-150.11%-1.1M	-299.24%-6.86M	-354.27%-1.97M
Net investment purchase and sale	166.88%60.47M	-10.57%-84.48M	-98.17%1.11M	19.37%-95.03M	-64.43%10.8M	39.00%-90.42M	---76.4M	--60.99M	---117.86M	--30.38M
Cash from discontinued investing activities
Investing cash flow	166.48%60.19M	-8.97%-84.63M	-98.26%1.04M	21.56%-97.82M	-63.08%10.49M	40.26%-90.54M	-6,688.55%-77.66M	13,679.14%59.88M	-7,155.26%-124.72M	6,661.43%28.41M
Financing cash flow
Cash flow from continuing financing activities	-37.60%624K	-100.16%-256K	48,002.70%214.06M	-0.01%163.54M	0	1.01%1M	-0.01%162.09M	222.46%445K	330.69%163.56M	-99.17%315K
Net common stock issuance	--0	-100.23%-365K	--213.7M	-0.08%161.82M	--0	0.00%-170K	--161.99M	--0	326.10%161.95M	--0
Proceeds from stock option exercised by employees	-46.67%624K	6.86%109K	-20.00%356K	6.45%1.72M	--0	0.86%1.17M	--102K	222.46%445K	2,832.73%1.61M	--315K
Cash from discontinued financing activities
Financing cash flow	-37.60%624K	-100.16%-256K	48,002.70%214.06M	-0.01%163.54M	--0	1.01%1M	-0.01%162.09M	222.46%445K	330.69%163.56M	-99.17%315K
Net cash flow
Beginning cash position	-58.84%88.22M	33.25%215.8M	-62.29%53.23M	-36.12%141.14M	-38.79%86.81M	-34.42%214.32M	-15.78%161.95M	-36.12%141.14M	-9.24%220.94M	-30.53%141.82M
Current changes in cash	106.92%8.83M	-343.64%-127.58M	681.15%162.57M	-10.17%-87.91M	-4,823.90%-33.58M	31.08%-127.51M	-61.07%52.36M	172.68%20.81M	-254.56%-79.8M	-104.06%-682K
End cash Position	11.79%97.05M	-58.84%88.22M	33.25%215.8M	-62.29%53.23M	-62.29%53.23M	-38.79%86.81M	-34.42%214.32M	-15.78%161.95M	-36.12%141.14M	-36.12%141.14M
Free cash flow	-37.20%-52.26M	-28.59%-42.85M	-29.49%-52.6M	-24.64%-156.42M	-41.47%-44.39M	-0.90%-38.09M	-20.74%-33.32M	-41.16%-40.62M	-107.50%-125.5M	-47.93%-31.38M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data